Researchers developed an intranasal H5N1 vaccine that protected mice and hamsters from bird flu infection. The vaccine was ...

Prior seasonal influenza virus immunity did not impair antibody responses or protection conferred by the intranasal H5N1 vaccine.

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans. When tested ...